Fred Alger Management, LLC Abiomed Inc Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $1.76 Million - $2.65 Million	-7,821 Reduced 96.87%	253 $63,000
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $1.28 Million - $1.69 Million	-4,613 Reduced 36.36%	8,074 $2.67 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $1.05 Million - $1.3 Million	-3,505 Reduced 21.65%	12,687 $4.56 Million
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $2.71 Million - $3.28 Million	8,730 Added 116.99%	16,192 $5.27 Million
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $15.2 Million - $20.4 Million	-57,967 Reduced 88.6%	7,462 $2.33 Million
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $145 Million - $180 Million	-506,098 Reduced 88.55%	65,429 $20.9 Million
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $401,244 - $516,450	1,593 Added 0.28%	571,527 $185 Million
Q3 2020 Nov 13, 2020	SELL	$255.22 - $317.0 $12.5 Million - $15.5 Million	-48,907 Reduced 7.9%	569,934 $158 Million
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $8.67 Million - $15.8 Million	61,329 Added 11.0%	618,841 $149 Million
Q1 2020 May 15, 2020	BUY	$130.51 - $196.01 $8.87 Million - $13.3 Million	68,001 Added 13.89%	557,512 $80.9 Million
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $7.72 Million - $10.8 Million	-48,469 Reduced 9.01%	489,511 $83.5 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $3.96 Million - $6.29 Million	-22,509 Reduced 4.02%	537,980 $95.7 Million
Q2 2019 Aug 14, 2019	BUY	$250.96 - $284.94 $32.5 Million - $36.9 Million	129,359 Added 30.0%	560,489 $146 Million
Q1 2019 May 14, 2019	SELL	$276.39 - $362.25 $43.9 Million - $57.6 Million	-159,004 Reduced 26.94%	431,130 $123 Million
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $9.11 Million - $14.4 Million	32,428 Added 5.81%	590,134 $192 Million
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $61.5 Million - $78 Million	173,466 Added 45.15%	557,706 $251 Million
Q2 2018 Jul 19, 2018	SELL	$278.07 - $446.21 $1.19 Million - $1.91 Million	-4,291 Reduced 1.1%	384,240 $157 Million
Q1 2018 May 10, 2018	SELL	$192.49 - $295.85 $21.3 Million - $32.8 Million	-110,763 Reduced 22.18%	388,531 $113 Million
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $20.6 Million - $24.3 Million	121,810 Added 32.27%	499,294 $93.6 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $54.9 Million - $63.6 Million	377,484	377,484 $63.6 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account